Cited by 105Phytoestrogen effects and researchNutritional Studies and DietPhytochemicals and Antioxidant Activities

Dietary isoflavones or isoflavone-rich food intake and breast cancer risk: A meta-analysis of prospective cohort studies

Zhao, Ting-Ting, Jin, Feng, Li, Ji-Guang, Xu, Ying-Ying, Dong, Hui-Ting, Liu, Qun, Xing, Peng, Zhu, Guo-Lian +2 more·2019·Clinical Nutrition

Abstract

Background & aims Previous studies implied that dietary isoflavone intake may reduce the risk of developing breast cancer, but some have shown ambiguous results. This study aimed to systematically evaluate and summarize available evidence on the effect dietary isoflavone intake has on the risk of developing breast cancer.Methods PubMed, Embase, and the Cochrane Library were searched for prospective cohort studies published through April 2017 that evaluated the effect of dietary isoflavone intake on the development of breast cancer.Results Sixteen prospective cohort studies, involving 11,169 breast cancer cases and 648,913 participants, were identified and included in our data analysis. The pooled relative risk (RR) of breast cancer was 0.99 for high versus low intake of isoflavones (95% confidence interval [CI], 0.91-1.09; P = 0.876) and 0.99 for moderate versus low intake of isoflavones (95%CI, 0.92-1.05; P = 0.653), with insignificant heterogeneity (P = 0.187 for high versus low, and P = 0.192 for moderate versus low). While a moderate consumption of soy-based foods did not significantly affect breast cancer risk, a high intake of soy-based foods associated with a lower risk of developing breast cancer. Considering specific foods, an increased the risk of developing breast cancer was seen with a moderate intake of formononetin, but no significant associations were found between breast cancer risk and other isoflavone-rich diets.Conclusions The present meta-analysis indicates that women with a high dietary intake of soy foods may experience a statistically significant reduction in breast cancer risk. However, moderate formononetin consumption may increase the risk of developing breast cancer.

Integrity signals

Registry

Crossref · 10.1016/j.clnu.2017.12.006

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A meta-analysis in 2016 and two more in 2019 suggested that soy food intake may be associated with a decrease in the risk of breast cancer and improved breast cancer survival.

    “A meta-analysis in 2016 and two more in 2019 reported similar conclusions and further suggested that soy food intake may be associated with a decrease in the risk of breast cancer and improved breast cancer survival [139,140,141].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, T.-T., Jin, F., Li, J.-G., Xu, Y.-Y., Dong, H.-T., Liu, Q., Xing, P., Zhu, G.-L., Xu, H., & Miao, Z.-F.
Affiliations
  • First Hospital of China Medical University (CN)
  • Sheng Jing Hospital (CN)
Corresponding author
Miao, Zhi-Feng
Venue
Clinical Nutrition
Publisher
Elsevier BV
Published
2019-02
Volume
38
Issue
1
Pages
136-145
ISSN
0261-5614 (ISSN-L)
OpenAlex
W2772817669
Cited by
105
References
44
Citations by year
2026: 1 · 2025: 8 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 22 · 2020: 14 · 2019: 13 · 2018: 3
FWCI
1.31
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81302125, 81372550)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
dietary isoflavones, breast cancer risk, soy products, formononetin, soy isoflavones, chemoprevention
MeSH terms
Breast Neoplasms, Diet, Humans, Isoflavones, Prospective Studies, Risk, Cohort Studies, Soybean Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review